Human papillomavirus vaccines and vaccine implementation

By de Sanjosé Silvia   Alemany Laia   Castellsagué Xavier   Bosch F Xavier  

Women's Health, Vol. 4, Iss. 6, 2008-11 ,pp. : 595-604

Future Medicine

Access to resources Recommend Favorite

Benefit–risk assessment of vitamin D supplementation

By Bischoff-Ferrari H.   Shao A.   Dawson-Hughes B.   Hathcock J.   Giovannucci E.   Willett W.  

Osteoporosis International, Vol. 21, Iss. 7, 2010-07 ,pp. : 1121-1132

Springer Publishing Company

Access to resources Recommend Favorite

Benefit–risk management in the age of personalized healthcare

By Forstner Michael  

Personalized Medicine, Vol. 9, Iss. 5, 2012-07 ,pp. : 507-514

Future Medicine

Access to resources Recommend Favorite

Integration of PKPD relationships into benefit–risk analysis

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 979-991

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human papillomavirus screening and vaccines for cancer prevention: what is on the horizon?

By Trimble Cornelia L   Gravitt Patti   Roden Richard BS  

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 295-303

Future Medicine

Access to resources Recommend Favorite